Changeflow GovPing Healthcare & Life Sciences Dry Needling vs ESWT in Lateral Epicondylitis S...
Routine Notice Added Final

Dry Needling vs ESWT in Lateral Epicondylitis Study, 60 Participants

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

A randomized single-blind controlled trial has been registered on ClinicalTrials.gov (NCT07550322) to compare the effectiveness of ultrasound-guided dry needling and extracorporeal shock wave therapy in patients with lateral epicondylitis (tennis elbow). The study will enroll 60 participants aged 18-65 years, randomized into two groups receiving one intervention once weekly for five sessions. All participants will receive a standardized home exercise program, with assessments at baseline, post-treatment, and 3- and 6-month follow-up.

“This randomized single-blind controlled trial aims to compare the effectiveness of ultrasound-guided dry needling and extracorporeal shock wave therapy in patients with lateral epicondylitis.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

This ClinicalTrials.gov registration documents a new randomized controlled trial comparing two non-invasive interventions for lateral epicondylitis. Sixty participants will be equally randomized to receive either ultrasound-guided dry needling with tendon fenestration or radial extracorporeal shock wave therapy, each administered once weekly for five sessions, alongside a standardized home exercise program.

Clinical trial sponsors, research institutions, and healthcare providers investigating musculoskeletal conditions may use this registered protocol as a reference for study design or patient counseling. Patients and investigators interested in participation should check enrollment status directly on ClinicalTrials.gov.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Dry Needling vs ESWT in Lateral Epicondylitis

N/A NCT07550322 Kind: NA Apr 24, 2026

Abstract

This randomized single-blind controlled trial aims to compare the effectiveness of ultrasound-guided dry needling and extracorporeal shock wave therapy in patients with lateral epicondylitis. Sixty participants aged 18-65 years will be randomized into two groups. The dry needling group will receive ultrasound-guided tendon fenestration once weekly for five sessions, while the ESWT group will receive radial extracorporeal shock wave therapy once weekly for five sessions. All participants will be given a standardized home exercise program. Pain, function, grip strength, pressure pain threshold, quality of life, and ultrasonographic findings will be evaluated at baseline, post-treatment, and at 3- and 6-month follow-up. The primary outcome is change in pain severity measured by Visual Analog Scale.

Conditions: Lateral Epicondylitis (Tennis Elbow)

Interventions: Ultrasound-guided dry needling, Extracorporeal Shock Wave Therapy

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial design Interventional study
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!